Shares of Envision Healthcare Corporation (NYSE:EVHC) have received an average recommendation of “Buy” from the fifteen ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $70.57.

A number of analysts have commented on the stock. Mizuho decreased their price target on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating for the company in a research note on Wednesday, August 9th. BidaskClub lowered shares of Envision Healthcare Corporation from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 17th. Royal Bank Of Canada upped their target price on shares of Envision Healthcare Corporation from $72.00 to $77.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 27th. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. Finally, Jefferies Group LLC set a $71.00 target price on shares of Envision Healthcare Corporation and gave the stock a “buy” rating in a research note on Thursday, August 24th.

COPYRIGHT VIOLATION WARNING: “Envision Healthcare Corporation (EVHC) Given Consensus Recommendation of “Buy” by Analysts” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/09/16/envision-healthcare-corporation-evhc-given-consensus-recommendation-of-buy-by-analysts.html.

In related news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the transaction, the insider now owns 97,863 shares in the company, valued at $6,135,031.47. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 3.10% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Commonwealth Bank of Australia grew its position in Envision Healthcare Corporation by 24.3% during the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock valued at $130,000 after buying an additional 410 shares during the period. Ameritas Investment Partners Inc. bought a new position in Envision Healthcare Corporation during the first quarter valued at about $172,000. First Interstate Bank bought a new position in Envision Healthcare Corporation during the first quarter valued at about $184,000. Daiwa Securities Group Inc. grew its position in Envision Healthcare Corporation by 60.9% during the first quarter. Daiwa Securities Group Inc. now owns 3,169 shares of the company’s stock valued at $194,000 after buying an additional 1,200 shares during the period. Finally, Nordea Investment Management AB grew its position in Envision Healthcare Corporation by 3.7% during the first quarter. Nordea Investment Management AB now owns 3,341 shares of the company’s stock valued at $205,000 after buying an additional 120 shares during the period. Institutional investors own 64.75% of the company’s stock.

Shares of Envision Healthcare Corporation (EVHC) opened at 48.49 on Friday. Envision Healthcare Corporation has a 1-year low of $47.47 and a 1-year high of $74.75. The firm’s market cap is $5.68 billion. The company has a 50 day moving average of $51.97 and a 200 day moving average of $57.86.

Envision Healthcare Corporation (NYSE:EVHC) last announced its quarterly earnings results on Monday, August 7th. The company reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.75 by $0.04. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. Envision Healthcare Corporation’s quarterly revenue was up 156.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.34 EPS. On average, equities analysts forecast that Envision Healthcare Corporation will post $1.40 earnings per share for the current fiscal year.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.